Activation of eosinophils interacting with dermal fibroblasts by pruritogenic cytokine IL-31 and alarmin IL-33: Implications in atopic dermatitis

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Wong, Chun Kwok ^a   Leung, Karen Ming Lam ^a   Qiu, Huai Na ^a   Chow, Joyce Yin Sau ^a   Choi, Angela On Kei ^a   Lam, Christopher Wai Kei ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CXCL1 CHEMOKINE; CYTOKINE RECEPTOR ANTAGONIST; ENZYME INHIBITOR; GAMMA INTERFERON INDUCIBLE PROTEIN 10; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 31; INTERLEUKIN 31 RECEPTOR; INTERLEUKIN 31 RECEPTOR ANTAGONIST; INTERLEUKIN 33; INTERLEUKIN 33 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; INTERLEUKIN RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; ONCOSTATIN M RECEPTOR BETA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RANTES; RECEPTOR; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; CCL2 PROTEIN, HUMAN; CCL5 PROTEIN, HUMAN; CELL SURFACE RECEPTOR; CXCL1 PROTEIN, HUMAN; CXCL10 PROTEIN, HUMAN; IL1RL1 PROTEIN, HUMAN; IL31 PROTEIN, HUMAN; IL31RA PROTEIN, HUMAN; IL33 PROTEIN, HUMAN; IL8 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; RECOMBINANT PROTEIN;

ARTICLE; ATOPIC DERMATITIS; CELL ACTIVATION; CELL SURFACE; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVATION; EOSINOPHIL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SIGNAL TRANSDUCTION; SKIN FIBROBLAST; WESTERN BLOTTING; CELL COMMUNICATION; CELL CULTURE; CYTOLOGY; DERMIS; DRUG EFFECT; FIBROBLAST; GENETICS; IMMUNOLOGY; METABOLISM;

BLOTTING, WESTERN; CELL COMMUNICATION; CELLS, CULTURED; CHEMOKINE CCL2; CHEMOKINE CCL5; CHEMOKINE CXCL1; CHEMOKINE CXCL10; COCULTURE TECHNIQUES; DERMATITIS, ATOPIC; DERMIS; EOSINOPHILS; FIBROBLASTS; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; INTERLEUKINS; RECEPTORS, CELL SURFACE; RECEPTORS, INTERLEUKIN; RECOMBINANT PROTEINS;

EID: 84855849824     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029815     Document Type: Article

References (51)

1. Bilsborough J, Leung DY, Maurer M, Howell M, Boguniewicz M, et al. (2006) IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis. J Allergy Clin Immunol 117: 418-425.
2. Dillon SR, Sprecher C, Hammond A, Bilsborough J, Rosenfeld-Franklin M, et al. (2004) Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 5: 752-760.
3. Takaoka A, Arai I, Sugimoto M, Honma Y, Futaki N, et al. (2006) Involvement of IL-31 on scratching behavior in NC/Nga mice with atopic-like dermatitis. Exp Dermatol 15: 161-167.
4. Grimstad O, Sawanobori Y, Vestergaard C, Bilsborough J, Olsen UB, et al. (2009) Anti-interleukin-31-antibodies ameliorate scratching behaviour in NC/Nga mice: a model of atopic dermatitis. Exp Dermatol 18: 35-43.
5. Williams HC, (2005) Clinical practice. Atopic dermatitis. N Engl J Med 352: 2314-2324.
6. Miraglia del Giudice M, Decimo F, Leonardi S, Maioello N, Amelio R, et al. (2006) Immune dysregulation in atopic dermatitis. Allergy Asthma Proc 27: 451-455.
7. Sonkoly E, Muller A, Lauerma AI, Pivarcsi A, Soto H, et al. (2006) IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol 117: 411-417.
8. Raap U, Wichmann K, Bruder M, Ständer S, Wedi B, et al. (2008) Correlation of IL-31 serum levels with severity of atopic dermatitis. J Allergy Clin Immunol 122: 421-423.
9. Neis MM, Peters B, Dreuw A, Wenzel J, Bieber T, et al. (2006) Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis. J Allergy Clin Immunol 118: 930-937.
10. Nobbe S, Dziunycz P, Mühleisen B, Bilsborough J, Dillon SR, et al. (2011) IL-31 Expression by Inflammatory Cells is Preferentially Elevated in Atopic Dermatitis. Acta Derm Venereol doi:10.2340/00015555-1191.
11. Dreuw A, Radtke S, Pflanz S, Lippok BE, Heinrich PC, et al. (2004) Characterization of the signaling capacities of the novel gp130-like cytokine receptor. J Biol Chem 279: 36112-36120.
12. Diveu C, Lak-Hal AH, Froger J, Ravon E, Grimaud L, et al. (2004) Predominant expression of the long isoform of GP130-like (GPL) receptor is required for interleukin-31 signaling. Eur Cytokine Netw 15: 291-302.
13. Jawa RS, Chattopadhyay S, Tracy E, Wan Y, Huntoon K, et al. (2008) Regulated Expression of the IL-31 Receptor in Bronchial and Alveolar Epithelial Cells, Pulmonary Fibroblasts, and Pulmonary Macrophages. J Interferon Cytokine Res 28: 207-219.
14. Kasraie S, Niebuhr M, Baumert K, Werfel T, (2011) Functional effects of interleukin 31 in human primary keratinocytes. Allergy 66: 845-852.
15. Cheung PF, Wong CK, Ho AW, Hu S, Chen DP, et al. (2010) Activation of human eosinophils and epidermal keratinocytes by Th2 cytokine IL-31: implication for the immunopathogenesis of atopic dermatitis. Int Immunol 22: 453-467.
16. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, et al. (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23: 479-490.
17. Liew FY, Pitman NI, McInnes IB, (2010) Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol 10: 103-110.
18. Chow JY, Wong CK, Cheung PF, Lam CW, (2010) Intracellular signaling mechanisms regulating the activation of human eosinophils by the novel Th2 cytokine IL-33: implications for allergic inflammation. Cell Mol Immunol 7: 26-34.
19. Kurowska-Stolarska M, Kewin P, Murphy G, Russo RC, Stolarski B, et al. (2008) IL-33 induces antigen-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4. J Immunol 181: 4780-4790.
20. Pushparaj PN, Tay HK, H'ng SC, Pitman N, Xu D, et al. (2009) The cytokine interleukin-33 mediates anaphylactic shock. Proc Natl Acad Sci USA 106: 9773-9778.
21. Pecaric-Petkovic T, Didichenko SA, Kaempfer S, Spiegl N, Dahinden CA, (2009) Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. Blood 113: 1526-1534.
22. Simon D, Braathen LR, Simon HU, (2004) Eosinophils and atopic dermatitis. Allergy 59: 561-570.
23. Bruijnzeel PL, Kuijper PH, Kapp A, Warringa RA, Betz S, et al. (1993) The involvement of eosinophils in the patch test reaction to aeroallergens in atopic dermatitis: its relevance for the pathogenesis of atopic dermatitis. Clin Exp Allergy 23: 97-109.
24. Matsuda H, Watanabe N, Geba GP, Sperl J, Tsudzuki M, et al. (1997) Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 9: 461-466.
25. Kiehl P, Falkenberg K, Vogelbruch M, Kapp A, (2001) Tissue eosinophilia in acute and chronic atopic dermatitis: a morphometric approach using quantitative image analysis of immunostaining. Br J Dermatol 145: 720-729.
26. Uehara M, Izukura R, Sawai T, (1990) Blood eosinophilia in atopic dermatitis. Clin Exp Dermatol 15: 264-266.
27. Jenerowicz D, Czarnecka-Operacz M, Silny W, (2006) Selected eosinophil proteins as markers of inflammation in atopic dermatitis patients. Acta Dermatovenerol Croat 14: 73-80.
28. Taniuchi S, Chihara J, Kojima T, Yamamoto A, Sasai M, (2001) Serum eosinophil derived neurotoxin may reflect more strongly disease severity in childhood atopic dermatitis than eosinophil cationic protein. J Dermatol Sci 26: 79-82.
29. Schröder JM, Mochizuki M, (1999) The role of chemokines in cutaneous allergic inflammation. Biol Chem 380: 889-896.
30. Hong SW, Kim MR, Lee EY, Kim JH, Kim YS, et al. (2011) Extracellular vesicles derived from Staphylococcus aureus induce atopic dermatitis-like skin inflammation. Allergy 66: 351-359.
31. Yoshihisa Y, Makino T, Matsunaga K, Honda A, Norisugi O, et al. (2011) Macrophage migration inhibitory factor is essential for eosinophil recruitment in allergen-induced skin inflammation. J Invest Dermatol 131: 925-931.
32. Kroeger KM, Sullivan BM, Locksley RM, (2009) IL-18 and IL-33 elicit Th2 cytokines from basophils via a MyD88- and p38alpha-dependent pathway. J Leukoc Biol 86: 769-778.
33. Chattopadhyay S, Tracy E, Liang P, Robledo O, Rose-John S, et al. (2007) Interleukin-31 and oncostatin-M mediate distinct signaling reactions and response patterns in lung epithelial cells. J Biol Chem 282: 3014-3026.
34. Toshitani A, Ansel JC, Chan SC, Li SH, Hanifin JM, (1993) Increased interleukin 6 production by T cells derived from patients with atopic dermatitis. J Invest Dermatol 100: 299-304.
35. Lee CE, Neuland ME, Teaford HG, Villacis BF, Dixon PS, et al. (1992) Interleukin-6 is released in the cutaneous response to allergen challenge in atopic individuals. J Allergy Clin Immunol 89: 1010-1020.
36. Bae CJ, Shim SB, Jee SW, Lee SH, Kim MR, et al. (2010) IL-6, VEGF, KC and RANTES are a major cause of a high irritant dermatitis to phthalic anhydride in C57BL/6 inbred mice. Allergol Int 59: 389-397.
37. Navarini AA, French LE, Hofbauer GF, (2011) Interrupting IL-6-receptor signaling improves atopic dermatitis but associates with bacterial superinfection. J Allergy Clin Immunol 128: 1128-1130.
38. Homey B, Steinhoff M, Ruzicka T, Leung DY, (2006) Cytokines and chemokines orchestrate atopic skin inflammation. J Allergy Clin Immunol 118: 178-189.
39. Rossi D, Zlotnik A, (2000) The biology of chemokines and their receptors. Annu Rev Immunol 18: 217-242.
40. Conti P, DiGioacchino M, (2001) MCP-1 and RANTES are mediators of acute and chronic inflammation. Allergy Asthma Proc 22: 133-137.
41. Wong CK, Lam CW, (2003) Clinical applications of cytokine assays. Adv Clin Chem 37: 1-46.
42. Wardlaw A, (2004) Eosinophil trafficking: new answers to old questions. Clin Exp Allergy 34: 676-679.
43. Farina G, York M, Collins C, Lafyatis R, (2011) dsRNA activation of endothelin-1 and markers of vascular activation in endothelial cells and fibroblasts. Ann Rheum Dis 70: 544-550.
44. Larson RS, Springer TA, (1990) Structure and function of leukocyte integrins. Immunol Rev 114: 181-217.
45. Nickoloff BJ, Griffiths CE, Barker JN, (1990) The role of adhesion molecules, chemotactic factors, and cytokines in inflammatory and neoplastic skin disease-1990 update. J Invest Dermatol 94: 151S-157S.
46. Wong CK, Cheung PF, Ip WK, Lam CW, (2007) Intracellular Signaling Mechanisms Regulating Toll-Like Receptor-Mediated Activation of Eosinophils. Am J Respir Cell Mol Biol 37: 85-96.
47. Wong CK, Cheung PF, Lam CW, (2007) Leptin-mediated cytokine release and migration of eosinophils: implications for immunopathophysiology of allergic inflammation. Eur J Immunol 37: 2337-2348.
48. Cheung PF, Wong CK, Lam CW, (2008) Molecular mechanisms of cytokine and chemokine release from eosinophils activated by IL-17A, IL-17F, and IL-23: implication for Th17 lymphocytes-mediated allergic inflammation. J Immunol 180: 5625-5630.
49. Pastore S, Mascia F, Mariotti F, Dattilo C, Mariani V, et al. (2005) ERK1/2 regulates epidermal chemokine expression and skin inflammation. J Immunol 174: 5047-5056.
50. Kanda N, Watanabe S, (2007) Leukotriene B(4) enhances tumour necrosis factor-alpha-induced CCL27 production in human keratinocytes. Clin Exp Allergy 37: 1074-1082.
51. Kim NH, Jeon S, Lee HJ, Lee AY, (2007) Impaired PI3K/Akt activation-mediated NF-kappaB inactivation under elevated TNF-alpha is more vulnerable to apoptosis in vitiliginous keratinocytes. J Invest Dermatol 127: 2612-2617.